Journal Article

Evaluation of TAM Receptor Targeting in Pathophysiology of Idiopathic Pulmonary Fibrosis

Gavelli, Francesco, Sainaghi, Pier Paolo, Bellan, Mattia, Zoppis, Elisa, Patrucco, Filippo, Vercellino, Nicole, Ferreira, Luciana L., Di Tizio, Alice, Sabihi Ahvaz, Zohre, Minisini, Rosalba

2025

Overview

Background and Objectives: TAM receptors—Tyro3, Axl, and Mer—and their ligand Growth Arrest-Specific 6 (Gas6) represent a pleiotropic system implicated in fibrosis. Increased Gas6 and Axl expression have previously been observed in lung samples and fibroblast cultures from Idiopathic Pulmonary Fibrosis (IPF) patients. The study explored the contribution of Gas6/TAM system in fibrosis development and the impact of its pharmacological inhibition in fibroblasts. Materials and Methods: IPF fibroblasts (IPF FBs) and control human pulmonary fibroblasts (HPFs) were treated with R428 (Axl-specific inhibitor), LDC1267 (TAM inhibitor), or Nintedanib (an IPF-approved drug) to evaluate the influence of these drugs on cell proliferation, migration, and the expression of pro-inflammatory and pro-fibrotic genes. Fibroblast-to-myofibroblast differentiation was induced by TGF-β. The impact of IPF FBs and HPF on macrophage polarization was investigated through a co-culture of fibroblasts with monocyte-derived macrophages, with the further gene expression analysis of markers of the M1 (pro-inflammatory) or M2 (pro-fibrotic) polarization forms. Results: Cell proliferation was monitored in fibroblasts treated with TGF-β, the drugs, and their combination. In the presence of LDC1267 and Nintedanib, minor differences in cell confluence were detected between IPF FBs and HPFs; R428 (1 μM) seemed to have a higher inhibitory impact on IPF FBs. Regarding cell migration, the fibroblasts treated with LDC1267 exhibited slower wound closure. R428 treatment led to a relative wound closure of 76% in HPFs but only 56% in IPF FBs (60 h). R428 (1 μM) significantly reduced the expression of the pro-fibrotic markers ACTA2, COL1A1, and FN1 in HPFs and IPF FBs compared to TGF-β treatment. HPFs and IPF FBs co-cultured with monocyte-derived macrophages demonstrated a significantly increased expression of MRC1 while the expression of FN1, TNFα, and CXCL10 was moderately increased. Conclusions: These findings suggest that R428 and LDC1267 modulate the proliferation, migration, and gene expression of activated fibroblasts via TAM signaling. Fibroblast-mediated effects on macrophage polarization underscore the relevance of intercellular crosstalk in fibrotic disease.

• Publisher: MDPI AG
• Subject: Axl Receptor Tyrosine Kinase / Bemcentinib / Benzocycloheptenes - pharmacology / Benzocycloheptenes - therapeutic use / c-Mer Tyrosine Kinase / Cell culture / Cell growth / Cell Movement - drug effects / Cell Proliferation - drug effects / Cells, Cultured / Development and progression / Drug approval / Fibroblasts / Fibroblasts - drug effects / Fibroblasts - metabolism / Fibronectins / fibrosis / Gas6 / Gene expression / Genes / Growth factors / Homeostasis / Humans / Idiopathic Pulmonary Fibrosis (IPF) / Idiopathic Pulmonary Fibrosis - drug therapy / Idiopathic Pulmonary Fibrosis - physiopathology / Indoles - pharmacology / Indoles - therapeutic use / Intercellular Signaling Peptides and Proteins / Kinases / Lung diseases / Macrophages / Medical research / Medicine, Experimental / Penicillin / Proto-Oncogene Proteins - antagonists & inhibitors / Pulmonary fibrosis / R428 / Receptor Protein-Tyrosine Kinases - antagonists & inhibitors / TAM receptors / Transforming growth factors / Triazoles / Wound healing